secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001193125-25-004941
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx reports preliminary Q4 revenue up 30% YoY to ~$85.5M; guides 2025 revenue $370M
--------------------------------------------------------------------------------

- Q4 revenue expected $85M-$86M, up ~30% YoY; testing services revenue $62.5M-$63.5M, up 35%.
- Full year 2024 revenue $332M-$333M; GAAP loss $58M-$60M; adjusted EBITDA gain $25M-$26M.
- Testing services volume ~45,500 in Q4, up 14% YoY; sixth consecutive quarter of volume growth.
- Cash, equivalents, and marketable securities ~$261M as of Dec 31, 2024, up $26M YoY.
- 2025 revenue guidance of $370M; targeting $500M revenue and 20% adjusted EBITDA by 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/0001193125-25-004941-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000119312525004941/d909876d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-004941

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer